BIVIGAM (KEDRION BIOPHARMA, INC.)
Welcome to the PulseAid listing for the BIVIGAM drug offered from KEDRION BIOPHARMA, INC.. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: | KEDRION BIOPHARMA, INC. |
NON-PROPRIETARY NAME: | HUMAN IMMUNOGLOBULIN G |
SUBSTANCE NAME: | HUMAN IMMUNOGLOBULIN G |
TYPE: | PLASMA DERIVATIVE |
PHARMA CLASS: | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2013-02-04 |
END MARKETING DATE: | 0000-00-00 |
BIVIGAM PLASMA DERIVATIVE Details:
Item Description | BIVIGAM from KEDRION BIOPHARMA, INC. |
LABELER NAME: | KEDRION BIOPHARMA, INC. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(g/10mL) |
START MARKETING DATE: | 2013-02-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 76125-918_f2d0d740-6f43-454c-9898-627be94f18e8 |
PRODUCT NDC: | 76125-918 |
APPLICATION NUMBER: | BLA125389 |
Other HUMAN IMMUNOGLOBULIN G Pharmaceutical Manufacturers / Labelers: